Patient Perspectives on the Ambulatory Glucose Profile (AGP) Report for Type 1 Diabetes Management: A National Online Survey

Published:January 07, 2023DOI:
      This paper is only available as a PDF. To read, Please Download here.



      Continuous and flash glucose monitoring devices produce data reports (e.g., ambulatory glucose profile, AGP) that can be used by the person with diabetes and health care providers (HCP). Clinical benefits of these reports have been published, however the patient perspective is under reported.


      We conducted an online survey for adults with type 1 diabetes (T1D) who use continuous/flash glucose monitoring to understand their use and attitudes towards the AGP report. Barriers and facilitators related to digital health technology were explored.


      The survey included 291 respondents: 63% were <40 years, and 65% lived with T1D for >15 years. Nearly 80% review their AGP report, with 50% often discussing it with their HCP. Support from family and HCPs was positively associated with the use of the AGP report, and there was a positive relationship between motivation and better understanding of the AGP report (OR:2.61,95%CI:1.45-4.71). Nearly all respondents (92%) consider the AGP report important for their diabetes management, but most were dissatisfied with the cost of the device. Open-ended responses indicated some concern with the complexity of information from the AGP report.


      This online survey found that there may be few barriers to the use of the AGP report by people with T1D, except for the cost of the devices. Facilitators for the use of the AGP report included motivation and support from both family and the HCP. Facilitating discussion between HCPs and patients may be a strategy to improve the use and potential benefit of the AGP report.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Canadian Journal of Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect